The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Role of NF-κB in Regulation of PXR-mediated Gene Expression
Open accessAbstract
It is a long-standing observation that inflammatory responses and infections decrease drug metabolism capacity in human and experimental animals. Cytochrome P-450 3A4 cyp304 is responsible for the metabolism of over 50% of current prescription drugs, and cyp3a4 expression is transcriptionally regulated by pregnane X receptor (PXR), which is a ligand-dependent transcription factor. In this study, we report that NF-kappaB activation by lipopolysaccharide and tumor necrosis factor-alpha plays a pivotal role in the suppression of cyp3a4 through interactions of NF-kappaB with the PXR.retinoid X receptor (RXR) complex. Inhibition of NF-kappaB by NF-kappaB-specific suppressor SRIkappaBalpha reversed the suppressive effects of lipopolysaccharide and tumor necrosis factor-alpha. Furthermore, we showed that NF-kappaB p65 disrupted the association of the PXR.RXRalpha complex with DNA sequences as determined by electrophoretic mobility shift assay and chromatin immunoprecipitation assays. NF-kappaB p65 directly interacted with the DNA-binding domain of RXRalpha and may prevent its binding to the consensus DNA sequences, thus inhibiting the transactivation by the PXR.RXRalpha complex. This mechanism of suppression by NF-kappaB activation may be extended to other nuclear receptor-regulated systems where RXRalpha is a dimerization partner.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Universal Protein Resource (UniProt)
Bairoch, A. (2004) · Nucleic Acids Research · doi:10.1093/nar/gki070 · Cited by 3,774
NF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1703 · Cited by 3,085
Lehmann, J. M., McKee, D. D., Watson, M. A., Willson, T. M., Moore, J. T., & Kliewer, S. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3703 · Cited by 1,576
Aggarwal, B. B. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.003 · Cited by 1,574
An Orphan Nuclear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling Pathway
Kliewer, S. A., Moore, J. T., Wade, L., Staudinger, J. L., Watson, M. A., Jones, S. A., McKee, D. D., Oliver, B. B., Willson, T. M., Zetterström, R. H., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)80900-9 · Cited by 1,539
CYTOCHROME P-450 3A4: Regulation and Role in Drug Metabolism
Guengerich, F. P. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.1 · Cited by 1,267
SXR, a novel steroid and xenobioticsensing nuclear receptor
Blumberg, B., Sabbagh, W., Juguilon, H., Bolado, J., van Meter, C. M., Ong, E. S., & Evans, R. M. (1998) · Genes & Development · doi:10.1101/gad.12.20.3195 · Cited by 919
Kast, H. R., Goodwin, B., Tarr, P. T., Jones, S. A., Anisfeld, A. M., Stoltz, C. M., Tontonoz, P., Kliewer, S., Willson, T. M., & Edwards, P. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109326200 · Cited by 916
Identification of a human nuclear receptor defines a new signaling pathway for CYP 3 A induction
Bertilsson, G., Heidrich, J., Svensson, K., Åsman, M., Jendeberg, L., Sydow-Bäckman, M., Ohlsson, R., Postlind, H., Blomquist, P., & Berkenstam, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12208 · Cited by 872
The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux
Synold, T. W., Dussault, I., & Forman, B. M. (2001) · Nature Medicine · doi:10.1038/87912 · Cited by 840
McKay, L. I., & Cidlowski, J. A. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0375 · Cited by 805
Enterohepatic bile salt transporters in normal physiology and liver disease
Kullak-ublick, G. A., Stieger, B., & Meier, P. J. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.06.005 · Cited by 658
Goodwin, B., Hodgson, E., & Liddle, C. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12400-5 · Cited by 646
Lehmann, V, Freudenberg, M. A., & Galanos, C. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.3.657 · Cited by 540
Reciprocal activation of Xenobiotic response genes by nuclear receptors SXR/PXR and CAR
Xie, W., Barwick, J. L., Simon, C. M., Pierce, A. M., Safe, S., Blumberg, B., Guzelian, P. S., & Evans, R. M. (2000) · Genes & Development · doi:10.1101/gad.846800 · Cited by 508
Self-citationRegulation of Cytochromes P450 During Inflammation and Infection
Morgan, E. T. (1997) · Drug Metabolism Reviews · doi:10.3109/03602539709002246 · Cited by 488
Induction of Drug Metabolism: The Role of Nuclear Receptors
Handschin, C., & Meyer, U. A. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.2 · Cited by 470
Ah Receptor and NF-κB Interactions, a Potential Mechanism for Dioxin Toxicity
Tian, Y., Ke, S., Denison, M. S., Rabson, A. B., & Gallo, M. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.510 · Cited by 405
Self-citationNa, S.-Y., Kang, B. Y., Chung, S. W., Han, S.-J., Ma, X., Trinchieri, G., Im, S.-Y., Lee, J. W., & Kim, T. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7674 · Cited by 233
Beischlag, T. V., Wang, S., Rose, D. W., Torchia, J., Reisz-Porszasz, S., Muhammad, K., Nelson, W. E., Probst, M. R., Rosenfeld, M. G., & Hankinson, O. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.12.4319-4333.2002 · Cited by 223
Ke, S., Rabson, A. B., Germino, J. F., Gallo, M. A., & Tian, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106286200 · Cited by 209
Self-citationBeigneux, A. P., Moser, A. H., Shigenaga, J. K., Grunfeld, C., & Feingold, K. R. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00196-1 · Cited by 192
Drug-activated nuclear receptors CAR and PXR
Honkakoski, P., Sueyoshi, T., & Negishi, M. (2003) · Annals of Medicine · doi:10.1080/07853890310008224 · Cited by 180
Cytochrome P450 Regulation and Drug Biotransformation During Inflammation and Infection
Renton, K. (2004) · Current Drug Metabolism · doi:10.2174/1389200043335559 · Cited by 179
Ah receptor and NF-κB interactions: mechanisms and physiological implications
Tian, Y., Rabson, A. B., & Gallo, M. A. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00068-6 · Cited by 176
Self-citationNF-κB, an Evolutionarily Conserved Mediator of Immune and Inflammatory Responses
Xiao, C., & Ghosh, S. (2005) · Advances in Experimental Medicine and Biology · doi:10.1007/0-387-24180-9_5 · Cited by 167
Cyp3A regulation: from pharmacology to nuclear receptors.
Quattrochi, L. C., & Guzelian, P. S. (2001) · PubMed · Cited by 162
Guo, G. L., Staudinger, J. L., Ogura, K., & Klaassen, C. D. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.4.832 · Cited by 127
Mechanisms of cytochrome P450 regulation by inflammatory mediators
Morgan, E. T., Li-Masters, T., & Cheng, P. (2002) · Toxicology · doi:10.1016/s0300-483x(02)00283-4 · Cited by 126
Wang, S., & Hankinson, O. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110122200 · Cited by 113
Interactions between the Aryl Hydrocarbon Receptor and P-TEFb
Tian, Y., Ke, S., Chen, M., & Sheng, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306443200 · Cited by 94
Self-citationRichardson, T. A., & Morgan, E. T. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.085456 · Cited by 86
Role of Mediator in Transcriptional Activation by the Aryl Hydrocarbon Receptor
Wang, S., Ge, K., Roeder, R. G., & Hankinson, O. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312274200 · Cited by 84
Martinez‐Jimenez, C. P., Gómez-Lechón, M. J., Castell, J. V., & Jover, R. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.008169 · Cited by 73
Goodwin, B. J., & Moore, J. T. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.06.007 · Cited by 48
Abdulla, D., Goralski, K. B., Cano, E. G. D. B., & Renton, K. W. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.004564 · Cited by 40
Goralski, K. B., Abdulla, D., Sinal, C. J., Arsenault, A., & Renton, K. W. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00562.2004 · Cited by 40
Cited by
Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory response
Wang, Y.-D., Chen, W.-D., Wang, M., Yu, D., Forman, B. M., & Huang, W. (2008) · Hepatology · doi:10.1002/hep.22519 · Cited by 639
Morgan, E. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.302 · Cited by 462
Molecular mechanisms underlying chemical liver injury
Gu, X., & Manautou, J. E. (2012) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411002110 · Cited by 381
Self-citationMolecular mechanisms of PFOA-induced toxicity in animals and humans: Implications for health risks
Li, K., Gao, P., Xiang, P., Zhang, X., Cui, X., & Ma, L. Q. (2017) · Environment International · doi:10.1016/j.envint.2016.11.014 · Cited by 260
Shah, Y. M., Ma, X., Morimura, K., Kim, I., & Gonzalez, F. J. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00528.2006 · Cited by 231
Metadata
- Authors
- Gu, X., Ke, S., Liu, D., Sheng, T., Thomas, P. E., Rabson, A. B., Gallo, M. A., Xie, W., & Tian, Y.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-06
- Volume
- 281
- Issue
- 26
- Pages
- 17882-17889
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2020872262
- Cited by
- 310
- References
- 37
- FWCI
- 12.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.